Pulmonary Arterial Hypertension in Systemic Sclerosis: Clinical Manifestations, Pathophysiology, Evaluation, and Management

Author： Ramirez Allan  

Publisher： Adis International

ISSN： 1176-3450

Source： Treatments in Respiratory Medicine, Vol.3, Iss.6, 2004-01, pp. : 339-352

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biomarkers in Systemic Sclerosis-Related Pulmonary Arterial Hypertension

By  

Current Vascular Pharmacology, Vol. 9, Iss. 2, 2011-01 ,pp. : 213-219

Bentham Science Publishers

Access to resources Recommend Favorite

N-Terminal probrain natriuretic peptide as a biochemical marker in the evaluation of bosentan treatment in systemic-sclerosis-related pulmonary arterial hypertension

By Dimitroulas Theodoros   Giannakoulas Georgios   Karvounis Haralambos   Koliakos Georgios   Sfetsios Tilemahos   Dimitroula Hara   Settas Loukas  

Clinical Rheumatology, Vol. 27, Iss. 5, 2008-05 ,pp. : 655-658

Springer Publishing Company

Access to resources Recommend Favorite

Systemic Sclerosis: Clinical Manifestations

By  

Current Rheumatology Reviews, Vol. 6, Iss. 4, 2010-11 ,pp. : 295-304

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension

By Chung Son-Mi   Lee Chang-Keun   Lee Eun   Yoo Bin   Lee Sang-Do   Moon Hee-Bom  

Clinical Rheumatology, Vol. 25, Iss. 6, 2006-11 ,pp. : 866-872

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of Clinical Efficacy of Fasudil for the Treatment of Pulmonary Arterial Hypertension

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 7, Iss. 2, 2012-01 ,pp. : 100-104

Bentham Science Publishers

Access to resources Recommend Favorite